Evoke Pharma Stock Price History
| EVOK Stock | USD 4.10 0.02 0.49% |
Below is the normalized historical share price chart for Evoke Pharma extending back to September 25, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Evoke Pharma stands at 4.10, as last reported on the 11th of December 2024, with the highest price reaching 4.22 and the lowest price hitting 4.03 during the day.
If you're considering investing in Evoke Stock, it is important to understand the factors that can impact its price. As of now, Evoke Stock is risky. Evoke Pharma secures Sharpe Ratio (or Efficiency) of 0.023, which denotes the company had a 0.023% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Evoke Pharma, which you can use to evaluate the volatility of the firm. Please confirm Evoke Pharma's Mean Deviation of 3.81, downside deviation of 5.08, and Coefficient Of Variation of 3548.88 to check if the risk estimate we provide is consistent with the expected return of 0.14%.
At this time, Evoke Pharma's Common Stock Total Equity is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 10.1 M this year, although the value of Other Stockholder Equity will most likely fall to about 75.9 M. . The value of Price To Sales Ratio is estimated to slide to 0.64. The value of Price Earnings Ratio is estimated to slide to -0.47. Evoke Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of September 2013 | 200 Day MA 5.726 | 50 Day MA 5.0565 | Beta 0.348 |
Evoke |
Sharpe Ratio = 0.023
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | EVOK | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.25 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Evoke Pharma is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evoke Pharma by adding it to a well-diversified portfolio.
Price Book 1.3888 | Enterprise Value Ebitda (0.36) | Price Sales 0.707 | Shares Float 969.5 K | Wall Street Target Price 18 |
Evoke Pharma Stock Price History Chart
There are several ways to analyze Evoke Stock price data. The simplest method is using a basic Evoke candlestick price chart, which shows Evoke Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 28, 2024 | 7.08 |
| Lowest Price | December 10, 2024 | 4.08 |
Evoke Pharma December 11, 2024 Stock Price Synopsis
Various analyses of Evoke Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Evoke Stock. It can be used to describe the percentage change in the price of Evoke Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Evoke Stock.| Evoke Pharma Price Daily Balance Of Power | 0.11 | |
| Evoke Pharma Price Rate Of Daily Change | 1.00 | |
| Evoke Pharma Accumulation Distribution | 566.35 | |
| Evoke Pharma Price Action Indicator | (0.02) |
Evoke Pharma December 11, 2024 Stock Price Analysis
Evoke Stock Price History Data
The price series of Evoke Pharma for the period between Thu, Sep 12, 2024 and Wed, Dec 11, 2024 has a statistical range of 3.06 with a coefficient of variation of 13.32. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.92. The median price for the last 90 days is 4.95. The company completed 1:12 stock split on 1st of August 2024.| Open | High | Low | Close | Volume | ||
| 12/11/2024 | 4.20 | 4.22 | 4.03 | 4.10 | 12,579 | |
| 12/10/2024 | 4.25 | 4.25 | 4.08 | 4.08 | 8,276 | |
| 12/09/2024 | 4.03 | 4.28 | 4.03 | 4.27 | 11,838 | |
| 12/06/2024 | 4.27 | 4.29 | 4.08 | 4.14 | 7,576 | |
| 12/05/2024 | 4.28 | 4.49 | 4.11 | 4.22 | 18,564 | |
| 12/04/2024 | 4.16 | 4.40 | 4.16 | 4.31 | 8,314 | |
| 12/03/2024 | 4.30 | 4.58 | 4.17 | 4.21 | 85,438 | |
| 12/02/2024 | 4.28 | 4.45 | 4.28 | 4.35 | 10,095 | |
| 11/29/2024 | 4.41 | 4.44 | 4.29 | 4.43 | 12,015 | |
| 11/27/2024 | 4.35 | 4.45 | 4.31 | 4.37 | 13,630 | |
| 11/26/2024 | 4.28 | 4.42 | 4.26 | 4.39 | 15,802 | |
| 11/25/2024 | 4.39 | 4.61 | 4.30 | 4.35 | 23,050 | |
| 11/22/2024 | 4.50 | 4.60 | 4.33 | 4.33 | 37,391 | |
| 11/21/2024 | 4.58 | 4.60 | 4.50 | 4.50 | 29,754 | |
| 11/20/2024 | 4.70 | 4.70 | 4.50 | 4.56 | 10,641 | |
| 11/19/2024 | 4.28 | 4.79 | 4.28 | 4.70 | 153,995 | |
| 11/18/2024 | 4.58 | 4.65 | 4.35 | 4.37 | 12,119 | |
| 11/15/2024 | 4.40 | 4.58 | 4.37 | 4.58 | 48,652 | |
| 11/14/2024 | 4.29 | 4.59 | 4.29 | 4.37 | 51,836 | |
| 11/13/2024 | 4.80 | 5.02 | 4.03 | 4.26 | 177,091 | |
| 11/12/2024 | 5.30 | 5.50 | 4.90 | 5.00 | 74,669 | |
| 11/11/2024 | 5.59 | 5.69 | 5.30 | 5.38 | 66,959 | |
| 11/08/2024 | 5.87 | 5.91 | 5.54 | 5.65 | 176,646 | |
| 11/07/2024 | 5.67 | 5.98 | 5.56 | 5.65 | 192,735 | |
| 11/06/2024 | 5.90 | 6.02 | 5.64 | 5.84 | 49,927 | |
| 11/05/2024 | 5.58 | 6.09 | 5.31 | 5.79 | 156,639 | |
| 11/04/2024 | 5.70 | 6.00 | 5.30 | 5.72 | 65,112 | |
| 11/01/2024 | 5.97 | 6.20 | 5.80 | 5.80 | 90,828 | |
| 10/31/2024 | 6.58 | 6.58 | 5.66 | 5.85 | 145,935 | |
| 10/30/2024 | 6.19 | 6.71 | 6.08 | 6.45 | 224,538 | |
| 10/29/2024 | 6.43 | 6.69 | 5.72 | 6.30 | 582,970 | |
| 10/28/2024 | 11.11 | 12.32 | 6.83 | 7.08 | 21,079,998 | |
| 10/25/2024 | 5.07 | 5.30 | 4.81 | 5.30 | 13,825 | |
| 10/24/2024 | 5.15 | 5.61 | 5.13 | 5.13 | 3,917 | |
| 10/23/2024 | 5.21 | 5.40 | 5.01 | 5.13 | 11,630 | |
| 10/22/2024 | 5.55 | 5.57 | 5.40 | 5.40 | 14,452 | |
| 10/21/2024 | 5.61 | 5.61 | 5.45 | 5.48 | 6,852 | |
| 10/18/2024 | 5.39 | 5.54 | 5.14 | 5.51 | 15,621 | |
| 10/17/2024 | 5.16 | 5.38 | 5.16 | 5.34 | 1,309 | |
| 10/16/2024 | 5.30 | 5.43 | 5.12 | 5.14 | 10,805 | |
| 10/15/2024 | 5.30 | 5.36 | 5.10 | 5.11 | 6,142 | |
| 10/14/2024 | 5.28 | 5.50 | 4.81 | 5.09 | 14,055 | |
| 10/11/2024 | 5.33 | 5.75 | 5.19 | 5.19 | 12,128 | |
| 10/10/2024 | 5.33 | 5.43 | 5.19 | 5.32 | 1,795 | |
| 10/09/2024 | 5.43 | 5.57 | 5.08 | 5.17 | 15,242 | |
| 10/08/2024 | 5.37 | 5.75 | 5.25 | 5.57 | 8,181 | |
| 10/07/2024 | 5.35 | 5.66 | 5.11 | 5.38 | 25,976 | |
| 10/04/2024 | 5.05 | 6.00 | 4.91 | 5.25 | 218,578 | |
| 10/03/2024 | 4.95 | 5.25 | 4.92 | 5.20 | 29,679 | |
| 10/02/2024 | 5.19 | 5.19 | 4.73 | 4.95 | 38,468 | |
| 10/01/2024 | 4.90 | 4.90 | 4.51 | 4.87 | 17,186 | |
| 09/30/2024 | 4.74 | 5.05 | 4.56 | 4.76 | 17,405 | |
| 09/27/2024 | 4.78 | 5.08 | 4.76 | 4.81 | 15,550 | |
| 09/26/2024 | 4.90 | 5.25 | 4.72 | 5.08 | 25,313 | |
| 09/25/2024 | 5.12 | 5.35 | 4.80 | 4.80 | 65,674 | |
| 09/24/2024 | 5.07 | 5.26 | 4.85 | 5.00 | 38,964 | |
| 09/23/2024 | 4.70 | 5.31 | 4.25 | 5.26 | 226,753 | |
| 09/20/2024 | 4.41 | 4.72 | 4.40 | 4.51 | 11,938 | |
| 09/19/2024 | 4.39 | 4.88 | 4.30 | 4.44 | 60,369 | |
| 09/18/2024 | 4.13 | 4.40 | 4.13 | 4.24 | 13,662 | |
| 09/17/2024 | 4.14 | 4.39 | 4.14 | 4.36 | 14,659 |
About Evoke Pharma Stock history
Evoke Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Evoke is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Evoke Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Evoke Pharma stock prices may prove useful in developing a viable investing in Evoke Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 278.6 K | 264.7 K | |
| Net Loss | -7.4 M | -7.8 M |
Evoke Pharma Quarterly Net Working Capital |
|
Evoke Pharma Stock Technical Analysis
Evoke Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Evoke Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Evoke Pharma's price direction in advance. Along with the technical and fundamental analysis of Evoke Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Evoke to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0292 | |||
| Jensen Alpha | 0.0378 | |||
| Total Risk Alpha | (0.82) | |||
| Sortino Ratio | 0.0098 | |||
| Treynor Ratio | 0.1487 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.13) | Revenue Per Share 7.792 | Quarterly Revenue Growth 0.698 | Return On Assets (0.34) | Return On Equity (3.50) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.